FR2940126B1 - Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase - Google Patents

Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase

Info

Publication number
FR2940126B1
FR2940126B1 FR0807366A FR0807366A FR2940126B1 FR 2940126 B1 FR2940126 B1 FR 2940126B1 FR 0807366 A FR0807366 A FR 0807366A FR 0807366 A FR0807366 A FR 0807366A FR 2940126 B1 FR2940126 B1 FR 2940126B1
Authority
FR
France
Prior art keywords
hmg
cosmetic
pharmaceutical
coa reductase
activator peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0807366A
Other languages
English (en)
Other versions
FR2940126A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0807366A priority Critical patent/FR2940126B1/fr
Priority to PCT/FR2009/001478 priority patent/WO2010072929A1/fr
Priority to US13/141,338 priority patent/US8546339B2/en
Publication of FR2940126A1 publication Critical patent/FR2940126A1/fr
Application granted granted Critical
Publication of FR2940126B1 publication Critical patent/FR2940126B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
FR0807366A 2008-12-23 2008-12-23 Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase Expired - Fee Related FR2940126B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0807366A FR2940126B1 (fr) 2008-12-23 2008-12-23 Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
PCT/FR2009/001478 WO2010072929A1 (fr) 2008-12-23 2009-12-23 Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
US13/141,338 US8546339B2 (en) 2008-12-23 2009-12-23 Soothing cosmetic or pharmaceutical composition comprising a peptide which activates HMG-CoA reductase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0807366A FR2940126B1 (fr) 2008-12-23 2008-12-23 Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase

Publications (2)

Publication Number Publication Date
FR2940126A1 FR2940126A1 (fr) 2010-06-25
FR2940126B1 true FR2940126B1 (fr) 2013-05-10

Family

ID=40941486

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0807366A Expired - Fee Related FR2940126B1 (fr) 2008-12-23 2008-12-23 Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase

Country Status (3)

Country Link
US (1) US8546339B2 (fr)
FR (1) FR2940126B1 (fr)
WO (1) WO2010072929A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104039611B (zh) 2012-01-11 2017-03-01 法国圣戈班玻璃厂 雨刮控制器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738510A3 (fr) 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
US7384910B2 (en) * 1997-10-08 2008-06-10 Castillo Gerardo M Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
FR2789312B1 (fr) 1999-02-05 2003-10-17 Seporga Sterol 3 sulfates, nouveaux principes actifs a usage cosmetique et dermatologique, et leurs applications
FR2798591B1 (fr) 1999-09-22 2001-10-26 Pharmascience Lab Utilisation d'un produit d'huile vegetale pour augmenter la synthese des lipides cutanes en cosmetique, pharmacie ou dermatologie et en tant qu'additif alimentaire
US6365138B1 (en) 2000-04-07 2002-04-02 The Regents Of The University Of California Compositions for metabolic protection and repair of lips
EP2301563A3 (fr) * 2001-08-23 2011-08-10 Board Of Regents Arizona Peptides HSP20
FR2848851B1 (fr) 2002-12-20 2006-03-10 Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues
FR2868309B1 (fr) * 2004-04-02 2006-05-26 Oreal Utilisation cosmetique d'au moins un inhibiteur d'hmg-coa-reductase comme agent destine a prevenir et/ou lutter contre les rides d'expression
US20080268077A1 (en) 2004-10-14 2008-10-30 Symrise Gmbh & Co. Kg Process for Strengthening the Barrier Function of Undamaged Skin
EP1960421B1 (fr) * 2005-12-15 2013-03-13 Sederma Nouveaux polypeptides et leur utilisation

Also Published As

Publication number Publication date
US20120014886A1 (en) 2012-01-19
US8546339B2 (en) 2013-10-01
FR2940126A1 (fr) 2010-06-25
WO2010072929A1 (fr) 2010-07-01

Similar Documents

Publication Publication Date Title
FR2944526B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
BRPI0917001A2 (pt) composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BRPI0913726A2 (pt) rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos
BRPI0917661A2 (pt) produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan
BR112013011868A2 (pt) compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BR112012002855A2 (pt) "uso de um anticorpo anti-cd20 afucosilado e composição"
BRPI0812575A2 (pt) Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, sequência de nucleotídeos
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
WO2012021786A3 (fr) Compositions d'anticorps anti-hemagglutinine et ses méthodes d'utilisation
DK2300472T3 (da) Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf
FR2961814B1 (fr) Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
BRPI0921699A2 (pt) complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo
FR18C1032I2 (fr) Anticorps anti-fgf23 et composition pharmaceutique le comprenant
BRPI0908859A2 (pt) composição farmacêutica estabilizada de líquído único contedo docetaxel
DE602006011790D1 (de) Lösungsmittelfreie formulierung von triclopyr-butoxyethylester
AP2010005249A0 (en) New antibodies specific of the B-amyloid peptides and their uses as diagnostic agents or drugs
FR2882810B1 (fr) Generateur de glacons de produits liquides ou pateux
BRPI0916069A2 (pt) "composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição"
FR2949782B1 (fr) Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant.
FR2958159B1 (fr) Compostion cosmetique ou pharmaceutique
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
BRPI0822782A2 (pt) composição farmacêutica que compreende rosuvastatina
ATE477712T1 (de) Flüssigformulierung von pyrethroiden
FR2940086B1 (fr) Formulation pharmaceutique de fenofibrate nanonise

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

ST Notification of lapse

Effective date: 20200910